Latest Aura Biosciences News & Updates

See the latest news and media coverage for Aura Biosciences. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Aura Biosciences

Biotechnology company developing targeted therapies for solid tumors

aurabiosciences.com
Headquarters
Boston, United States
Founded year
2009
Company type
Public company
Number of employees
125–200

Latest news about Aura Biosciences

Company announcements

  • Aura Biosciences

    Aura Biosciences announces proposed public offering

    It is offering common stock and pre-funded warrants; underwriters have a 30-day option to purchase up to 15% additional shares.

  • Aura Biosciences

    Aura Biosciences appoints Natalie Holles as CEO

    She succeeds founder Elisabet de los Pinos. Phase 3 CoMpass trial nears enrollment completion with 86 patients enrolled.

  • Aura Biosciences

    Aura Biosciences reports Q4 and full-year 2025 financial results

    Cash totals $144.2M, funding into Q1 2027. Phase 3 CoMpass enrollment accelerates to mid-2026 completion. NMIBC trial data expected mid-2026. New formulation achieves 12-month stability.

  • Aura Biosciences

    Aura Biosciences reports Q3 2025 financial results

    Cash stands at $161.9M, funding into H1 2027. Phase 3 CoMpass enrollment completes 2026, topline data Q4 2027. NMIBC trial data expected mid-2026.

Unlock all announcements with a

Media coverage

Unlock all articles with a

Never miss news about Aura Biosciences

Track Aura Biosciences and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Aura Biosciences competitors & trending companies

Browse news for competitors to Aura Biosciences and other trending companies.